Announcement • Mar 26
Fufeng Group Limited, Annual General Meeting, May 29, 2026 Fufeng Group Limited, Annual General Meeting, May 29, 2026. Announcement • Mar 16
Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026 Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026 Announcement • Aug 18
Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025 Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025 Announcement • Mar 28
Fufeng Group Limited, Annual General Meeting, May 29, 2025 Fufeng Group Limited, Annual General Meeting, May 29, 2025. Announcement • Mar 18
Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025 Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025 Declared Dividend • Sep 01
First half dividend of HK$0.18 announced Shareholders will receive a dividend of HK$0.18. Ex-date: 10th September 2024 Payment date: 30th September 2024 Dividend yield will be 12%, which is higher than the industry average of 8.1%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 44% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 31
First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023) First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Announcement • Aug 20
Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024 Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024 Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to HK$4.43, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 9x in the Chemicals industry in Hong Kong. Total returns to shareholders of 148% over the past three years. Upcoming Dividend • May 27
Upcoming dividend of HK$0.35 per share Eligible shareholders must have bought the stock before 03 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 33% but the company is not cash flow positive. Trailing yield: 7.2%. Lower than top quartile of Hong Kong dividend payers (7.6%). Higher than average of industry peers (4.7%). Announcement • Mar 28
Fufeng Group Limited, Annual General Meeting, May 30, 2024 Fufeng Group Limited, Annual General Meeting, May 30, 2024. Reported Earnings • Mar 28
Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022) Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Announcement • Mar 27
Fufeng Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 Fufeng Group Limited proposed final dividend of HKD 0.22 per share for the year ended 31 December 2023. Date of shareholders' approval is 30 May 2024. Ex-dividend date is 03 June 2024. Record date is 07 June 2024. Payment date is 28 June 2024. Announcement • Mar 16
Fufeng Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024 Fufeng Group Limited announced that they will report fiscal year 2023 results on Mar 27, 2024 Upcoming Dividend • Sep 11
Upcoming dividend of HK$0.23 per share at 13% yield Eligible shareholders must have bought the stock before 18 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.6%). Reported Earnings • Sep 01
First half 2023 earnings released: EPS: CN¥0.61 (vs CN¥0.80 in 1H 2022) First half 2023 results: EPS: CN¥0.61 (down from CN¥0.80 in 1H 2022). Revenue: CN¥13.6b (up 5.0% from 1H 2022). Net income: CN¥1.54b (down 24% from 1H 2022). Profit margin: 11% (down from 16% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Announcement • Aug 31
Fufeng Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2023 Fufeng Group Limited announced Interim Dividend of HKD 0.23 per share for the six months ended 30 June 2023. Record date is 22 September 2023. Payment date is 13 October 2023. Ex-dividend date is 18 September 2023. Announcement • Aug 19
Fufeng Group Limited to Report First Half, 2023 Results on Aug 30, 2023 Fufeng Group Limited announced that they will report first half, 2023 results on Aug 30, 2023 Announcement • Aug 01
Fufeng Group Limited Announces Management Changes, Effect from 1 August 2023 The board of directors of Fufeng Group Limited announced that Mr. Lee Wai Yin (Mr. Lee) has tendered his resignation as company secretary and authorised representative of the Company with effect from 1 August 2023. The Board announced that Mr. Yau Wing Yiu (Mr. Yau) will be appointed as the company secretary and authorised representative of the Company with effect from 1 August 2023. Mr. Yau joined the Group as chief financial officer since June 2021. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. The biography of Mr. Yau could be referenced to the 2022 annual report of the Company. Upcoming Dividend • May 29
Upcoming dividend of HK$0.33 per share at 13% yield Eligible shareholders must have bought the stock before 05 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.3%). Reported Earnings • Mar 31
Full year 2022 earnings released: EPS: CN¥1.52 (vs CN¥0.51 in FY 2021) Full year 2022 results: EPS: CN¥1.52 (up from CN¥0.51 in FY 2021). Revenue: CN¥27.5b (up 28% from FY 2021). Net income: CN¥3.86b (up 202% from FY 2021). Profit margin: 14% (up from 5.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 31
First half 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.23 in 1H 2021) First half 2022 results: EPS: CN¥0.80 (up from CN¥0.23 in 1H 2021). Revenue: CN¥12.9b (up 36% from 1H 2021). Net income: CN¥2.03b (up 243% from 1H 2021). Profit margin: 16% (up from 6.2% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.7% while the Chemicals industry in Hong Kong is not expected to grow. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 5% per year. Valuation Update With 7 Day Price Move • Jul 03
Investor sentiment improved over the past week After last week's 21% share price gain to HK$5.03, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 39% over the past three years. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment improved over the past week After last week's 16% share price gain to HK$4.33, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 27% over the past three years. Upcoming Dividend • May 30
Upcoming dividend of HK$0.12 per share Eligible shareholders must have bought the stock before 06 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Hong Kong dividend payers (7.8%). In line with average of industry peers (5.4%). Reported Earnings • Apr 27
Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020) Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 19%, compared to a 12% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Recent Insider Transactions • Apr 06
Principal Founder & Executive Chairman recently bought HK$3.2m worth of stock On the 1st of April, Xuechun Li bought around 1m shares on-market at roughly HK$3.18 per share. This was the largest purchase by an insider in the last 3 months. This was Xuechun's only on-market trade for the last 12 months. Reported Earnings • Apr 01
Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020) Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.2% compared to a 8.3% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improved over the past week After last week's 17% share price gain to HK$2.87, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 20% over the past three years. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improved over the past week After last week's 16% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 14% over the past three years. Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment improved over the past week After last week's 19% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 17% over the past three years. Upcoming Dividend • Sep 06
Upcoming dividend of HK$0.098 per share Eligible shareholders must have bought the stock before 13 September 2021. Payment date: 30 September 2021. Trailing yield: 4.8%. Lower than top quartile of Hong Kong dividend payers (6.6%). Higher than average of industry peers (2.9%). Reported Earnings • Sep 03
First half 2021 earnings released: EPS CN¥0.23 (vs CN¥0.15 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥9.52b (up 17% from 1H 2020). Net income: CN¥591.0m (up 56% from 1H 2020). Profit margin: 6.2% (up from 4.6% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment improved over the past week After last week's 16% share price gain to HK$2.92, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 6.2% over the past three years. Executive Departure • Jun 16
Chief Financial Officer Yuan Chen has left the company On the 15th of June, Yuan Chen's tenure as Chief Financial Officer ended after 3.9 years in the role. We don't have any record of a personal shareholding under Yuan's name. A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 3.92 years. Upcoming Dividend • May 31
Upcoming dividend of HK$0.041 per share Eligible shareholders must have bought the stock before 07 June 2021. Payment date: 30 June 2021. Trailing yield: 3.2%. Lower than top quartile of Hong Kong dividend payers (6.0%). Lower than average of industry peers (3.6%). Reported Earnings • Apr 25
Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 13% per year. Executive Departure • Apr 01
Independent Non-Executive Director has left the company On the 1st of April, Zheng Yu's tenure as Independent Non-Executive Director ended after 8.3 years in the role. We don't have any record of a personal shareholding under Zheng's name. A total of 3 executives have left over the last 12 months. Reported Earnings • Mar 26
Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year. Is New 90 Day High Low • Feb 20
New 90-day high: HK$3.76 The company is up 33% from its price of HK$2.82 on 20 November 2020. The Hong Kong market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$12.17 per share. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥3.64, the stock is trading at a trailing P/E ratio of 8.5x, up from the previous P/E ratio of 7.3x. This compares to an average P/E of 9x in the Chemicals industry in Hong Kong. Total return to shareholders over the past three years is a loss of 14%. Is New 90 Day High Low • Jan 18
New 90-day high: HK$3.10 The company is up 25% from its price of HK$2.48 on 21 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 27% over the same period. Is New 90 Day High Low • Nov 16
New 90-day high: HK$2.80 The company is up 4.0% from its price of HK$2.69 on 18 August 2020. The Hong Kong market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is down 4.0% over the same period. Recent Insider Transactions • Oct 06
CEO & Executive Director recently bought HK$1.3m worth of stock On the 30th of September, Deheng Li bought around 541k shares on-market at roughly HK$2.40 per share. This was the largest purchase by an insider in the last 3 months. This was Deheng's only on-market trade for the last 12 months. Is New 90 Day High Low • Sep 22
New 90-day low: HK$2.43 The company is down 5.0% from its price of HK$2.56 on 24 June 2020. The Hong Kong market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$10.93 per share.